High affinity open channel block by dofetilide of HERG expressed in a human cell line

Molecular Pharmacology

Volumn 49, Issue 6, 1996, Pages 949-955

  Snyders, Dirk J ^a,b   Chaudhary, Archana ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOFETILIDE;

ARTICLE; CHANNEL GATING; DRUG RECEPTOR BINDING; HEART MUSCLE POTENTIAL; HUMAN; HUMAN CELL; LONG QT SYNDROME; PRIORITY JOURNAL; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; CATION TRANSPORT PROTEINS; CELL LINE; DNA-BINDING PROTEINS; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; LONG QT SYNDROME; PHENETHYLAMINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SULFONAMIDES; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0029942250     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shibasaki, T. Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. J. Physiol. (Lond.) 387:227-250 (1987).
2. + current: differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96:195-215 (1990).
3. Balser, J. R., P. B. Bennett, and D. M. Roden. Time-dependent outward current in guinea pig ventricular myocytes: gating kinetics of the delayed rectifier. J. Gen. Physiol. 96:835-863 (1990).
4. + channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). Circ. Res 75:870-878 (1994).
5. K, by flecainide and E4031 in cat ventricular myocytes. Circulation 82:289-293 (1990).
6. Kr) in AT-1 cells: concentration-, time-, voltage-, and use-dependent effects. Circulation 91:1799-1806 (1995).
7. + current in cardiac myocytes by dofetilide. J. Pharmacol. Exp. Ther. 262:809-817 (1992).
8. + current by dofetilide. Circ. Res. 72:75-83 (1993).
9. Colatsky, T. J., and T. M. Argentieri. Potassium channel blockers as antiarrhythmic drugs. Drug Dev. Res. 33:235-249 (1994).
10. Roden, D. M. Current status of class III antiarrhythmic drug therapy. Am. J. Cardiol. 72:44B-49B (1993).
11. Warmke, J. W., and B. Ganetzky. A family of potassium channel genes related to eag in Drosophila and mammals. Proc. Natl. Acad. Sci. USA 91:3438-3442 (1994).
12. Curran, M. E., I. Splawski, K. W. Timothy, G. M. Vincent, E. D. Green, and M. T. Keating. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell 80:795-803 (1995).
13. Kr potassium channel. Cell 81:299-307 (1995).
14. Trudeau, M. C., J. W. Warmke, B. Ganetzky, and G. A. Robertson. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science (Washington D. C.) 269:92-95 (1995).
15. Wang, Z., B. Fermini, and S. Nattel. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc. Res. 28:1540-1546 (1994).
16. Ohler, A., G J. Amos, E. Wettwer, and U. Ravens. Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:602-610 (1994).
17. + channel. Drug Dev. Res. 34:376-380 (1995).
18. Chalfie, M., Y. Tu, G. Euskirchen, W. W. Ward, and D. C. Prasher. Green fluorescent protein as a marker for gene expression. Science (Washington D. C.) 263:802-805 (1994).
19. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch. Eur. J. Physiol. 391:85-100 (1981).
20. Snyders, D. J., K. M Knoth, S. L. Roberds, and M M. Tamkun. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol. Pharmacol. 41:322-330 (1992).
21. Snyders, D. J., and S. W. Yeola. Determinants of antiarrhythmic drug action: electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ. Res. 77:575-583 (1995).
22. Kr, and effects on myocardial refractoriness for class III antiarrhythmic agents. J. Cardiovasc. Pharmacol. 25:336-340 (1995).
23. 3H]dofetilide binding to guinea pig myocytes. Circ. Res. 77:718-725 (1995).
24. + channel as a target for class III methanesulfonanilides. Circ. Res. 77:1151-1155 (1995).
25. Veldkamp, M. W., A. C van Ginneken, and L. N. Bouman. Single delayed rectifier channels in the membrane of rabbit ventricular myocytes. Circ. Res. 72:365-878 (1993).
26. + channel. Circ. Res. 72:707-714 (1993).
27. + channels. Proc. Natl. Acad. Sci. USA 88:5092-5095 (1991).